Anti-metallothionein IgG and levels of metallothionein in autistic children with GI disease

Drug, Healthcare and Patient Safety

Volumn 1, Issue 1, 2009, Pages 1-8

  Russo, A J ^a  

^a MOUNT ST MARY S UNIVERSITY   (United States)

Author keywords

Anti metallothionein; Autism; GI disease; Metallothionein

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; METALLOTHIONEIN; METALLOTHIONEIN ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; AUTISM; AUTOIMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MALE; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL;

EID: 77953403660     PISSN: None     EISSN: 11791365     Source Type: Journal    
DOI: 10.2147/dhps.s4342     Document Type: Article

References (37)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington D.C.: American Psychiatric Association; 1994.
2. Gillberg C, Coleman M. The Biology of the Autistic Syndromes, 2nd ed. London: Mac Keith Press; 1992.
3. Filipek P, Accardo P, Baranek G, et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord. 1999;29:439-484.
4. Bailey A, Phillips W, Rutter M. Autism: towards an integration of clinical, genetic, neuro-psychological, and neurobiological perspectives. J Child Psychol Psychiatry. 1996;37:89-126.
5. Suzuki T, Takemoto TI, Kashiwazaki H, Miyama T. Metabolic fate of ethylmercury salts in man and animal. In: Miller MW, Clarkson TW, editors. Mercury, Mercurials, and Mercaptans. Springfi eld, IL: Charles C Thomas; 1973;12:209-233.
6. Halsey NA. Perspective on the use of thimerosal-containing vaccines. Presentation at the National Vaccine Advisory Committee Workshop on Thimerosal and Vaccines, Institute of Vaccine Safety. Aug 11-12, 1999. Cited on Dec 2, 2008. Available from: http://www.vaccinesafety.edu/.
7. Egan WM. Thimerosal in Vaccines. Presentation to the FDA. Sept 14, 1999.
8. Davis LE, Kornfeld M, Mooney HS, et al. Methyl mercury poisoning: long term clinical, radiological, toxicological, and pathological studies of an affected family. Ann Neurol. 1994;35:680-688.
9. Bernard S, Enayati A, Roger H, Binstock T, Redwood T, McGinnis W. Autism: A Unique Type of Mercury Poisoning. ARC Research Report, April, 2000. Cited on Dec 2, 2008. Available from: http://www.vaccinationnews.com/ DailyNews/July2001/AutismUniqueMercPoison.htm.
10. Schubert J, Riley E, Tyler S. Combined effects in toxicology, a rapid systemic testing procedure: cadmium, mercury and lead. J Toxicol Environ Health. 1978;4:763-776.
11. Pichichero ME, Gentile A, Giglio N, et al. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. Pediatrics. 2008;121:e208-14.
12. Fombonne E. Thimerosal disappears but autism remains. Arch Gen Psychiatry. 2008;65:15-16.
13. Schechter R, Grether JK. Continuing increases in autism reported to California's developmental services system: mercury in retrograde. Arch Gen Psychiatry. 2008;65:19-24.
14. Goering PL, Klaassen CD. Hepatotoxicity of metals. In: Metals Toxicology. Academic Press, San Diego; 1995. pp. 339-361.
15. Klaassen CD, Habeebu SSM. Role of metallothionein in cadmium-induced hepatotoxicity. In: Lee SK, Surh Y-J, editors. Trends in Biopharmaceutical and Toxicological Sciences. Seoul National University Press, Seoul; 1998. pp. 1-17.
16. Takeda A, Kodama Y, Okada S. Metallothionein induction in rat brain after intrastriatal injection of zinc and cadmium salts. J Health Sci. 1999;45:20-23.
17. Koizumi S, Suzuki K, Ogra Y, Gong P, and Otuska F. Roles of zinc fi ngers and other regions of the transcription factor human MTF-1 in zinc-regulated DNA binding. J Cell Physiol. 2000;185:464-472.
18. Aschner M, Cherian MG, Klaassen CD, Palmiter RD, Erickson JC, Bush AI. Metallothioneins in brain - the role in physiology and pathology. Toxicol Appl Pharmacol. 1997;142:229-242.
19. Goering PL, Klaassen CD. Hepatotoxicology of copper, iron, and cadmium. Comprehensive Toxicology. 1997;9:389-406.
20. Cherian MG, Chan HM. Biological functions of metallothionein - a review. In: Suzuki KT, Imura N, Kimura M, editors. Metallothionein III. Basel: Birkhauser Verlag; 1993. pp. 87-109.
21. van Gent T, Heijnen CJ, Treffers PDA. Autism and the immune system. J Child Psychol Psychiatry. 1997;38:337-349.
22. Hu H, Möller G, Abedi-Valugerdi M. Mechanism of mercury-induced autoimmunity: both T helper 1- and T helper 2-type responses are involved. Immunology. 1999;96:348-357.
23. Singh VK. Plasma increase of interleukin-12 and interferon-gamma: pathological significance in autism. J Neuroimmunol. 1996;66:143-145.
24. Singh VK. Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin Immunol Immunopathol. 1998;89:105-108.
25. Walsh W, Usman A. Metal metabolism and autism. Presented at the American Psychiatric Association Annual Meeting, May 10, 2001. New Orleans, LA.
26. Grider A, Bailey LB, Cousins RJ. Erythrocyte metallothionein as an index of zinc status in humans. Proc Nat Acad Sci U S A. 1990;87:1259-1262.
27. Warren R, Odell J, Warren W, et al. Immunoglobulin A defi ciency in a subset of autistic subjects. J Autism Develop Dis. 1997;27:187-192.
28. Warren R, Margaretten N, Pace N, Foster A. Immune abnormalities in patients with autism. J Autism Develop Dis. 1986;16:189-197.
29. Warren R, Singh V, Cole P, et al. Possible association of the extended MHC haplotype B44-SC30-DR4 with autism. Immunogenetics. 1992;36:203-207.
30. Warren R, Yonk J, Burger R, Odell J, Warren W. DR positive T cells in autism: association with decreased plasma levels of the complement C4B protein. Neuropsychobiology. 1995;31:53-57.
31. Gupta S, Aggarwal, Heads C. Dysregulated immune system in children with autism. Benefi cial effects of intravenous immune globulin on autistic characteristics. Autism Develop Dis. 1996;26:439-452.
32. Bagenstose LM, Salgame P, Monestier M. Murine mercury-induced autoimmunity: a model of chemically related autoimmunity in humans. Immunol Res. 1999;20:67-78.
33. Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol. 1999;14:388-394.
34. Singh VK, Hanson J. Assessment of metallothionein and antibodies to metallothionein in normal and autistic children having exposure to vaccine-derived thimerosal. Pediatr Allergy Immunol. 2006;17:291-296.
35. Jin GB, Nakayama H, Shmyhlo M, et al. High positive frequency of antibodies to metallothionein and heat shock protein 70 in sera of patients with metal allergy. Clin Exp Immunol. 2003;131:275-279.
36. Singh VK, Hanson J. Assessment of metallothionein and antibodies to metallothionein in normal and autistic children having exposure to vaccine-derived thimerosal. Pediatr Allergy Immunol. 2006;17:291-296.
37. Russo AJ. Anti-metallothionein IgG and levels of metallothionein in autistic families. Swiss Med Weekly. 2008;138:70-77.